Perseus Proteomics Inc.
Status: Publicly traded
Direct answer
Perseus Proteomics Inc. is publicly traded on JPX under the ticker 4882.T.
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract...
Can you invest in Perseus Proteomics Inc.?
Yes. Perseus Proteomics Inc. is publicly traded on JPX under the ticker 4882.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Perseus Proteomics Inc.
Detailed equity research is provided by MarketSnap.